Rossari Biotech Limited

NSEI:ROSSARI Stock Report

Market Cap: ₹50.5b

Rossari Biotech Future Growth

Future criteria checks 4/6

Rossari Biotech is forecast to grow earnings and revenue by 21.3% and 15.2% per annum respectively while EPS is expected to grow by 21.3% per annum.

Key information

21.3%

Earnings growth rate

21.3%

EPS growth rate

Chemicals earnings growth20.4%
Revenue growth rate15.2%
Future return on equityn/a
Analyst coverage

Low

Last updated24 Jul 2024

Recent future growth updates

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Earnings and Revenue Growth Forecasts

NSEI:ROSSARI - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202624,8381,9761,204N/A4
3/31/202521,1611,606367N/A3
6/30/202419,0961,364N/AN/AN/A
3/31/202418,3061,307-880433N/A
12/31/202317,6431,255N/AN/AN/A
9/30/202316,8981,168-341631N/A
6/30/202316,3181,078N/AN/AN/A
3/31/202316,5591,0731,1871,516N/A
12/31/202216,8831,027N/AN/AN/A
9/30/202217,275995729990N/A
6/30/202216,8661,018N/AN/AN/A
3/31/202214,830977-89294N/A
12/31/202112,623957N/AN/AN/A
9/30/202110,438948-342129N/A
6/30/20218,310892N/AN/AN/A
3/31/20217,093802-103478N/A
12/31/20206,507729N/AN/AN/A
9/30/20206,0316951981,045N/A
6/30/20205,818666N/AN/AN/A
3/31/20206,001653-191568N/A
3/31/20195,162457272712N/A
3/31/20182,922254N/A254N/A
3/31/20172,350143N/A67N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ROSSARI's forecast earnings growth (21.3% per year) is above the savings rate (6.7%).

Earnings vs Market: ROSSARI's earnings (21.3% per year) are forecast to grow faster than the Indian market (17% per year).

High Growth Earnings: ROSSARI's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ROSSARI's revenue (15.2% per year) is forecast to grow faster than the Indian market (10% per year).

High Growth Revenue: ROSSARI's revenue (15.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ROSSARI's Return on Equity is forecast to be high in 3 years time


Discover growth companies